Effect of spironolactone on the progression of coronary calcification in peritoneal dialysis patients: a pilot study.
Ana Paula Santana GueirosJosé Edevanilson de Barros GueirosKarina Tavares NóbregaEveline Barros CaladoMarina Cadena da MattaLeuridan Cavalcante TorresAlex Sandro Rolland SouzaDulce Elena CasariniAluizio Barbosa de CarvalhoPublished in: Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (2019)
In peritoneal dialysis patients, spironolactone did not attenuate the progression of CC. However, large-scale studies are needed to confirm this observation. Disorders of mineral metabolism and dyslipidemia are involved in the progression of CC.